May 21 |
Insider Stock Buying Reaches US$709.0k On ESSA Pharma
|
May 14 |
ESSA Pharma GAAP EPS of -$0.20 misses by $0.01
|
May 14 |
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
|
Apr 9 |
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
Apr 8 |
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
|
Mar 8 |
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
|
Feb 26 |
12 $10 Stocks That Will Triple
|
Feb 16 |
EPIX: Risk Profile of Patients in Phase 1/2 Trial of Masofaniten Reveals Majority at High Risk for Early Enzalutamide Failureā¦
|
Feb 14 |
ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results
|
Feb 13 |
ESSA Pharma GAAP EPS of -$0.14
|